ARTICLE | Company News
Atrix, MediGene deal
April 9, 2001 7:00 AM UTC
ATRX granted MDG exclusive European marketing rights to Leuprogel leuprolide in one, three and four month preparations to treat prostate cancer. MDG will fund clinical research and regulatory activit...